Free Newsletter
| Get the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Sign up for free today! |
Brits to vaccinate schoolgirls against HPV
The British government just made Merck's day--or was it GlaxoSmithKline's? U.K. schoolgirls will be vaccinated against the human papilloma virus that causes cervical cancer. And it's not just the 12- and 13-year-olds initially recommended to get the shot, but young women up to age 18, too.
The government stopped short of recommending which version of the vaccine to use. Both Gardasil, made by Merck and Sanofi Pasteur, and Cervarix, made by Glaxo, are approved for use in the U.K. Glaxo's version launched only recently, while Merck has had more time to get a toehold in the market.
- read the story at the BBC's website
Be the first to comment
Comments
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness


